Most Popular Stories
- SPOTLIGHT: World Privacy Forum sounds alarm over PHR services
- HIMSS report: $25 billion stimulus needed to help speed EMR adoption
- Google, Microsoft PHRs sign health plan partners
- Study: EMR market should grow 14 percent annually through 2012
- CBO says health IT only cost-effective solution to healthcare reform
- HHS releases new infection-control action plan
Featured Jobs
-
California Pulmonologist
StaffPointe, LLC - north , CA -
Kansas Neuropsychologist
StaffPointe, LLC - northeast , KS -
Ohio Radiologist
StaffPointe, LLC - west central , OH -
Ohio Internal Medicine
StaffPointe, LLC - south central , OH -
Kansas PMR Physician
StaffPointe, LLC - northeast , KS
Events
- Healthcare Conference at Harvard Business School on January 17, 2009
- National Health Policy Conference (NHPC)
Feb 2-3, 2009 — Washington, DC - CIO Healthcare Summit
May 10-13 — Scottsdale, AZ - Four Seasons
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
- Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Free Newsletter
FierceHealthIT is the leading source of Healthcare IT news with a special focus on CPOE, EMR adoption, HIPAA compliance and other critical areas. Join 25,000+ healthcare industry insiders who get FierceHealthIT via weekly email for their must know IT news. Sign up today!
About | View Sample | Privacy
Latest News
Popular Topics
Whitepapers
- Open Source and Healthcare IT
- Can a National Healthcare Information Network Work?
- The Definitive IP Address Management (IPAM) Intelligence Whitepaper
- Premerus Issues Study Addressing Medical Misdiagnosis in America 2008
- Redesigning Patient Flow
- Financing Options for Nonprofit Rural and Community Hospitals
Drugmakers agree to six-month DTC delay
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are approved before advertising to the public. The Congressmen pressuring the drug companies--Bart Stupak (D-MI) and John Dingell (D-MI)--aren't pleased, however, given that what they wanted was a two year DTC moratorium. Besides, even the drug companies themselves admit that they generally don't advertise within the first six months after product introductions anyway, given that they usually spend at least that much time educating doctors about drugs before beginning consumer advertising. Meanwhile, the pharmas turned down other requests, including that they only advertise products when studies have shown that they improve clinical outcomes (rather than having used biomarkers). (Looks like they gave up a whole lot of nothing, in other words.) The promise to delay on DTC advertising came as part of a hearing focused on ads for Pfizer's Lipitor, Johnson & Johnson's Procrit, and Merck/Schering-Plough's cholesterol drug Vytorin.
To learn more about the hearing:
- read this Wall Street Journal blog
Related Articles:
Who will pay for DTC pharma ad oversight?
Drugmakers face direct-to-consumer ad ban
AMA to study the impact of drug advertising
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





